| dc.contributor.author | Chowdhury, Rajdeep | |
| dc.contributor.author | Roy, Aniruddha | |
| dc.date.accessioned | 2024-01-11T06:31:28Z | |
| dc.date.available | 2024-01-11T06:31:28Z | |
| dc.date.issued | 2020-07 | |
| dc.identifier.uri | https://link.springer.com/article/10.1007/s43440-020-00122-1 | |
| dc.identifier.uri | http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13807 | |
| dc.description.abstract | Recent studies have demonstrated that autophagy plays a critical role in reducing the drug sensitivity of docetaxel (DTX) therapy. Disulfiram (DSF) has exhibited potent autophagy inducing activity in multiple studies. We hypothesized that DSF co-treatment could sensitize breast cancer cells to DTX therapy via autophagy modulation. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Springer | en_US |
| dc.subject | Pharmacy | en_US |
| dc.subject | Disulfiram | en_US |
| dc.subject | Breast cancer | en_US |
| dc.subject | Autophagy | en_US |
| dc.title | Disulfiram potentiates docetaxel cytotoxicity in breast cancer cells through enhanced ROS and autophagy | en_US |
| dc.type | Article | en_US |
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||